1/9
07:03 pm
cprx
Does Forbes' Small-Cap Honor for Sales Growth Reshape the Bull Case For Catalyst Pharmaceuticals (CPRX)? [Yahoo! Finance]
Low
Report
Does Forbes' Small-Cap Honor for Sales Growth Reshape the Bull Case For Catalyst Pharmaceuticals (CPRX)? [Yahoo! Finance]
1/9
04:31 am
cprx
Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? [Yahoo! Finance]
Low
Report
Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? [Yahoo! Finance]
1/8
08:03 am
cprx
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
Low
Report
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
1/5
08:40 am
cprx
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) [Yahoo! Finance]
Low
Report
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) [Yahoo! Finance]
1/5
08:03 am
cprx
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
Low
Report
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
12/31
11:40 am
cprx
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? [Yahoo! Finance]
12/24
04:13 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
12/18
04:34 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
12/18
11:42 am
cprx
Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 [Yahoo! Finance]
Low
Report
Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 [Yahoo! Finance]
12/17
02:23 am
cprx
Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift [Yahoo! Finance]
Low
Report
Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift [Yahoo! Finance]
12/15
02:08 pm
cprx
BioFlorida Fuels Innovation: Awards $90,000 in Annual Pitch Competition [Yahoo! Finance]
Low
Report
BioFlorida Fuels Innovation: Awards $90,000 in Annual Pitch Competition [Yahoo! Finance]
12/15
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/13
06:40 pm
cprx
Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi-Year Share Price Surge? [Yahoo! Finance]
Medium
Report
Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi-Year Share Price Surge? [Yahoo! Finance]
12/12
04:13 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
12/10
10:39 am
cprx
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) [Yahoo! Finance]
Low
Report
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) [Yahoo! Finance]
12/4
05:36 am
cprx
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
Low
Report
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
12/3
05:38 pm
cprx
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
Low
Report
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
11/28
01:37 am
cprx
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
11/24
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Low
Report
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
11/19
08:03 am
cprx
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
Low
Report
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
11/18
08:03 am
cprx
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
Low
Report
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
11/16
01:09 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at
Wall
11/15
07:05 pm
cprx
Is Catalyst Pharmaceuticals Still a Bargain After Pipeline Expansion and 8% Weekly Gain? [Yahoo! Finance]
Low
Report
Is Catalyst Pharmaceuticals Still a Bargain After Pipeline Expansion and 8% Weekly Gain? [Yahoo! Finance]
11/7
04:03 pm
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
11/7
09:05 am
cprx
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..